A  

Yes. Population‐based analysis found that proportionally fewer elderly patients with oropharyngeal squamous cell carcinoma received surgery and/or radiotherapy compared with younger cohorts, indicating undertreatment despite evidence of survival benefit from aggressive therapy [Camilon, 2014, PMID 24591144].